YDES
YD Bio Ltd
7.40$
-2.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | -15.9% | -359.9% | -1,105.3% | |
| – | – | – | 0.7% | 20.5% | 35.1% | |
| – | – | – | -36.2% | -111.3% | -282.4% | |
| – | – | – | 0.1% | 570.4% | 241.3% | |
| – | – | – | -0.1% | -568.4% | -241.3% | |
| – | – | – | -9.3% | -6.5% | 0.0% | |
| – | – | – | 32.5% | 1,514.2% | 1,821.2% | |
| – | – | – | 16.3% | 596.7% | 481.8% | |
| – | – | – | -16.0% | -930.3% | -1,346.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.